Home » Topics » BioWorld Science

BioWorld Science
RSS

RemeGen discloses new anti-c-Met antibody-drug conjugates

April 1, 2022

CNRS and collaborators patent acetylcholinesterase reactivators

April 1, 2022

New NFE2-related factor 2 activators described by Sanofi

April 1, 2022

Galderma discovers JAK-1 inhibitors

April 1, 2022

Medshine Discovery divulges thyroid hormone receptor beta agonists

April 1, 2022

BLU-945 for treatment-resistant EGFR T790M mutation-driven lung cancer

April 1, 2022

Zelluna collaborates with Etcembly and Nextera to optimize pipeline TCRs

March 31, 2022

Deleting protein switches macrophages to reduced-fat diet

March 31, 2022

New cathepsin L inhibitors for the treatment of HCC

March 31, 2022

Eloxx expands ELX-02 development program to include Alport syndrome

March 31, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...